Search

discovery was the development of mRNA vaccines. After decades of research, rather ironically, the COVID-19 pandemic accelerated the validation of the use of mRNA in the form of vaccines for the treatment of infectious [...] regulatory authorities. This resulted in the acceleration of marketing authorizations for COVID-19 vaccines, increased knowledge of disease mechanisms, and the potential development of new mRNA-based therapies [...] immunotherapies, therapeutic protein replacement therapies, and genetic disease treatment. However, mRNA delivery itself still poses multiple challenges with regard to developing the optimal formulation/delivery

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

The importance of collaborative efforts in generating new vaccines to protect a vulnerable world

What have we learned from the pandemic and how can we address the coming challenges?

University “The success of the mRNA vaccine technology for COVID-19, I believe, has huge implications for the cancer vaccine field and, ultimately, for combination vaccine and cell therapy approaches for

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

recent breakthrough discovery was the development of mRNA vaccines. The COVID-19 pandemic accelerated the validation of the use of mRNA in the form of vaccines for the treatment of infectious diseases, which

The pharmaceutical industry experienced its fair share of challenges and success in 2021. We break down the sector's biggest moments here.

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.